Related Experiment Video
Updated: Jun 13, 2026
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
When Blasts Speak Louder Than Flow: A Diagnostic Challenge in Suspected Hematologic Malignancy
Alireza Izadian Bidgoli1,2, Alberto Gomez Veliz2, Maria Vermejo Blumen3
1Internal Medicine, American University of the Caribbean School of Medicine, Cupecoy, SXM.
Early diagnosis of hematologic malignancies can be challenging when initial diagnostic studies are discordant, particularly because flow cytometry, although central to evaluation, may be non-diagnostic in evolving disease. We report the case of a 33-year-old female who presented with leukocytosis, systemic symptoms, and progressive hematologic abnormalities, including circulating blasts identified on peripheral blood analysis. Initial diagnostic evaluation included laboratory studies, peripheral smear review, and flow cytometry, followed by cross-sectional imaging that demonstrated an anterior mediastinal mass, lymphadenopathy, and hepatosplenomegaly concerning for lymphoproliferative malignancy. Despite strong clinical suspicion, early flow cytometric findings were insufficient for definitive classification, prompting escalation to bone marrow biopsy with comprehensive immunophenotypic and cytogenetic analysis. Bone marrow examination ultimately demonstrated T-lymphoblastic leukemia/lymphoma with an abnormal immature T-cell population and isolated ABL1 copy number gain in the absence of BCR::ABL1 fusion. The hospital course was further complicated by catheter-associated upper extremity thrombosis. This case highlights the limitations of isolated diagnostic modalities in early hematologic malignancy and underscores the importance of integrating clinical, laboratory, morphologic, immunophenotypic, and imaging findings. Persistent clinical suspicion should prompt timely tissue-based evaluation despite initially inconclusive studies to avoid delays in definitive diagnosis and management.
Early diagnosis of hematologic malignancies can be challenging when initial diagnostic studies are discordant, particularly because flow cytometry, although central to evaluation, may be non-diagnostic in evolving disease. We report the case of a 33-year-old female who presented with leukocytosis, systemic symptoms, and progressive hematologic abnormalities, including circulating blasts identified on peripheral blood analysis. Initial diagnostic evaluation included laboratory studies, peripheral smear review, and flow cytometry, followed by cross-sectional imaging that demonstrated an anterior mediastinal mass, lymphadenopathy, and hepatosplenomegaly concerning for lymphoproliferative malignancy. Despite strong clinical suspicion, early flow cytometric findings were insufficient for definitive classification, prompting escalation to bone marrow biopsy with comprehensive immunophenotypic and cytogenetic analysis. Bone marrow examination ultimately demonstrated T-lymphoblastic leukemia/lymphoma with an abnormal immature T-cell population and isolated ABL1 copy number gain in the absence of BCR::ABL1 fusion. The hospital course was further complicated by catheter-associated upper extremity thrombosis. This case highlights the limitations of isolated diagnostic modalities in early hematologic malignancy and underscores the importance of integrating clinical, laboratory, morphologic, immunophenotypic, and imaging findings. Persistent clinical suspicion should prompt timely tissue-based evaluation despite initially inconclusive studies to avoid delays in definitive diagnosis and management.
